Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2021 Jan 8.
Published in final edited form as: J Am Board Fam Med. 2020 Nov-Dec;33(6):969–977. doi: 10.3122/jabfm.2020.06.200210

Educating Patients on Unnecessary Antibiotics: Personalizing potential harm aids patient understanding

Benjamin J Miller 1, Kathryn A Carson 2, Sara Keller 3
PMCID: PMC7791407  NIHMSID: NIHMS1657337  PMID: 33219075

Abstract

Introduction:

Antibiotic resistance is a public health emergency fueled by inappropriate antibiotic use. Public education campaigns often focus on global antibiotic resistance or societal harm of antibiotic misuse. There has been little research into what messages have the greatest impact on patient preferences for non-indicated antibiotics in ambulatory clinics.

Methods:

We administered a survey at a primary care clinic in Baltimore, MD. 250 participants rated 18 statements about potential harm from antibiotics on how each statement changed their likelihood to request antibiotics for an upper respiratory tract infection (URI). Statements focused on potential harm either to the individual, to contacts of the individual, to society, and related or not to antibiotic resistance. Initial and final likelihood of requesting antibiotics was measured, and the impact of the statements in each category were compared using general linear models and Wilcoxon rank sum or Kruskal-Wallis tests.

Results:

All statements decreased patient likelihood to request antibiotics. Statements about harm to the individual or contacts of the individual decreased participant likelihood to request antibiotics significantly more than statements about societal harm of antibiotic misuse. Statements not discussing antibiotic resistance decreased participant likelihood of requesting antibiotics significantly more than statements discussing antibiotic resistance. Overall likelihood to request antibiotics decreased after the survey by 2.2 points on an 11-point Likert scale (p<0.001).

Conclusion:

When dissuading patients from requesting non-indicated antibiotics, providers and public health campaigns should focus on potential harm of non-indicated antibiotics to the individual rather than societal harm or antibiotic resistance.

Keywords: Antibiotic Resistance, Antibiotic Stewardship, Antibiotic Prescription, Ambulatory care

Introduction:

While progress has been made in antibiotic stewardship, antibiotic resistance is increasing at an alarming rate. Antibiotic-resistant organisms cause more than 2.8 million infections and 35,000 deaths per year in the United States [1]. In 2015, approximately 47 million antibiotic courses were prescribed for infections not needing antibiotics [1].

Many interventions aimed at improving antibiotic use in ambulatory settings have focused on clinician behavior. However, clinicians cite perceived patient desire for antibiotics, impact of patient satisfaction scores, time demands, or lack of patient understanding about negative impacts of harmful antibiotic use as several reasons they may prescribe antibiotics for conditions where they are not indicated, such as for upper respiratory infections (URIs) [2] [3]. Studies have shown that when physicians perceive that patients expect antibiotics, the physician is ten times more likely to prescribe an antibiotic [4] [2].

To decrease unnecessary antibiotic prescriptions, clinicians may benefit from an improved understanding of how to communicate with patients about antibiotics. Patients may not appreciate the negative impact of taking non-indicated antibiotics [3], and it is unclear what information clinicians could provide to patients that has the greatest impact on patient desire for antibiotics. There is limited data on the effectiveness of specific language meant to dissuade patients’ desire and requests for antibiotics for non-indicated conditions. While public health campaigns have often focused on global antibiotic resistance, little research has directly compared this approach with more personal messaging [5] [6].

The purpose of this study was to determine which statements most deter requests for antibiotics for non-indicated conditions by effectively communicating the risks associated with antibiotics. We hypothesized that statements about potential harm to the individual patient or contacts of the individual patient from unnecessary antibiotics would decrease participant desire for antibiotics more than statements about societal harm from non-indicated antibiotics.

Methods:

Survey Instrument:

We developed a survey with 18 statements in 4 categories. Participants rated each statement based on the impact on patient likelihood of requesting antibiotics for a URI. Each statement described a potential harm caused by antibiotics. Eight statements described potential harm to the individual taking the antibiotics, four statements described potential harm to people close to the individual taking the antibiotics, and six statements described potential harm to society. In addition, eight of the statements discussed harm caused by antibiotic resistance while ten of the statements did not discuss antibiotic resistance. To increase readability, statements were edited to utilize short sentences, words with few syllables, and clear sentence structure. The average Flesch-Kincaid readability score was grade 10.6. The survey was piloted with ten adults, five female and five male, with ages ranging from 19-58 and education level ranging from high school completion to advanced degree completion. Statements were refined for clarity and were narrowed from 24 to 18 in number based on pilot feedback, with the deletion of questions that were reported to be the most confusing or repetitive (See Appendix).

Participation was requested by visual signage. Surveys were delivered in random question order either on paper (N=40) or an electronic tablet using the Qualtrics survey platform (N=210), based on participant preference. Participants read each statement and then rated on a 11-point Likert scale how that statement changed their likelihood to request antibiotics for a URI. A “0” meant the statement made the patient much less likely to request antibiotics and “10” meant the statement made them much more likely to request antibiotics. We utilized an 11 point Likert scale to allow for a neutral choice (5), and since we anticipated most responses would fall on the “less likely” side of neutral, 5 options on either side of neutral provided more distinction between choices than 3 or 4 options. We wished to keep a 0-10 scale with neutral as 5 as this is the way people are used to seeing surveys. However to report the data we transposed the neutral “5” value to a Delta Mean of “0,” the prior value of “0” to a delta mean of “−5,” and the prior score of “10” to “5.” Delta means more clearly display that the most effective statements had a large negative delta mean, while less effective statements had a less negative delta mean. Before and after reading the 18 statements, participants were asked about their overall likelihood of requesting antibiotics for a URI.

Population:

Our survey was available to adults in the waiting room of an outpatient internal medicine and obstetrics and gynecology practice in Baltimore, MD on weekdays between July 20, 2018 to July 27, 2018. Participants were not required to be patients of the clinic (for example, they could have been a family member waiting with a clinic patient). Participants received a $10 gift card upon completion of the survey.

Statistical Analysis

Many of the survey response data were not normally distributed. Therefore, results were summarized using both non-parametric (medians, interquartile ranges [IQRs]) and parametric (means, standard deviations [SDs]) statistics. Group comparisons were made using Wilcoxon rank sum or Kruskal-Wallis tests. General linear models regression was used to estimate the least squares means of the change in the likelihood of requesting antibiotics following the 18 statements. Statistical analysis was performed using SAS version 9.4 (SAS Institute, Inc., Cary, NC). All tests were two-sided, and significance was set at p<0.05.

Results:

Of 1150 total adult patients in clinic and an unknown number of family members or others accompanying these patients during the 6-day course of the survey administration, 250 adults took the survey. Researchers were not allowed to approach any patients, and the 250 participants approached only after seeing signage. These 250 people were out of an unknown number of the 1,150 patients in clinic who actually saw and read the signage. Most participants were women (N= 184, 73.6%), most had completed at least some college or trade school (N=140, 56%), and most were African American (N=152, 61%) (Table 1).

Table 1:

Characteristics of 250 adult participants in a survey about harms of antibiotic use

Characteristic Count (%)
Sex
Male 64 (25.6%)
Female 184 (73.6%)
Other 2 (0.8%)
Age
18-24 18 (7.2%)
25-34 70 (28.0%)
35-44 43 (17.2%)
45-54 40 (16.0%)
55-64 40 (16.0%)
65+ 39 (15.6%)
Education
High School Graduate or less 54 (21.6%)
Any college or trade school up to bachelor’s degree 140 (56.0%)
Master’s Degree or Higher 56 (22.4%)
Race/Ethnicity
White (Non-Hispanic/Latino) 69 (27.6%)
Black or African American 152 (60.8%)
All others 29 (11.6%)
Living Situation
I live with family members or roommates 190 (76.0%)
I live by myself 60 (24%)

The initial likelihood of requesting antibiotics for a URI like illness was a raw mean score of 5.3 (Slightly more likely to request antibiotics than not, as “5” meant “I may or may not request antibiotics”). After participants completed the survey, this likelihood decreased to a raw mean of 3.1 (“3 meant “I probably will not request antibiotics”, p<0.001) for a mean delta of −1.9. All statements reduced participant likelihood of requesting antibiotics (Table 2). The most impactful statement was “Taking antibiotics can hurt your body's natural defenses. This makes it easier for you to get another infection” with a change from neutral (5) in mean likelihood of requesting antibiotics (mean delta) of −2.56 while the least effective statement was "Antibiotic resistance costs the U.S. between $20-35 billion each year” with a delta mean of −1.35.

Table 2:

Change in Likelihood of Requesting Antibiotics for URI-Like Symptoms After Reading Each Statement About Potential Harm of Non-Indicated Antibiotics

Statement Delta
Mean
Likelihood
(Standard
Deviation)
Median
(Interquartile
range)
Statement
Category
Discusses
Antibiotic
Resistance?
"Taking antibiotics can hurt your body's natural defenses. This makes it easier for you to get another infection"[1] [9]. −2.56 (2.14) −3 (−5 to −1) Individual No
"Antibiotics can change how babies grow inside pregnant women" [10] [11] −2.54 (2.28) −3 (−5 to 0) Others close to you No
"By changing your normal gut bacteria, antibiotics can cause allergies, asthma, and stomach problems" [10] [12] [13]. −2.54 (2.21) −3 (−5 to −1) Individual No
"Antibiotics can make you more likely to be obese (fat)" [14] −2.51 (2.28) −3 (−5 to 0) Individual No
"Pregnant women who take antibiotics are more likely to have babies with asthma" [11]. −2.50 (2.33) −3 (−5 to 0) Others close to you No
"Antibiotics can cause bad bacteria to overgrow in your gut. This can cause diarrhea and belly pain" [15] [12]. −2.47 (2.17) −3 (−5 to −1) Individual No
"In the future, antibiotic resistance will cause more deaths than cancer and diabetes combined” [6] −2.42 (2.23) −3 (−5 to 0) Society Yes
"Resistant bacteria can still be found in your gut four years after taking antibiotics" [16] −2.30 (2.25) −3 (−4 to 0) Individual Yes
"A single dose of antibiotics makes the bacteria in your body more resistant to treatment" [17] −2.12 (2.26) −2 (−4 to 0) Individual Yes
"Antibiotics kill your normal gut bacteria. This can cause bad bacteria to overgrow" [14] −1.99 (2.35) −2 (−4 to 0) Individual No
"Antibiotic resistant bacteria cause over two million illnesses and twenty-three thousand deaths in the U.S. each year" [9] −1.96 (2.45) −2 (−4 to 0) Society Yes
"Each antibiotic resistant infection costs up to $30,000 more to treat than other infections" [18] [19] [6]. −1.93 (2.30) −2 (−4 to 0) Society Yes
"Taking antibiotics can cause you to get a yeast infection" [20]. −1.90 (2.46) −2 (−4 to 0) Individual No
"Resistant bacteria can spread between people" [1] [9]. −1.85 (2.66) −2 (−4 to 0) Others close to you Yes
"Antibiotics are the most common cause of Emergency Room visits for drug reactions in children" [9]. −1.83 (2.33) −2 (−4 to 0) Others close to you No
"One in five people who take an antibiotic in a hospital will have a side effect" [1]. −1.72 (2.25) −2 (−4 to 0) Society No
"In some countries like India, people in hospitals have infections so resistant that antibiotics can't treat them" [21] −1.40 (2.60) −1 (−4 to 0) Society Yes
"Antibiotic resistance costs the U.S. between $20-35 billion each year" [18] [9]. −1.35 (2.28) −1 (−3 to 0) Society Yes

For the mean delta displayed, a “−5” meant the statement made the patient much less likely to request antibiotics, “0” meant the statement did not change their likelihood, and “5” would mean the statement made them much more likely to request antibiotics.

Statements about both individual harm and harm to contacts of an individual had a significantly greater reduction in likelihood of requesting antibiotics (delta mean −2.30 and −2.18 respectively) than statements about harm to society (delta mean −1.80; p<0.001 for both individual harm and harm to contacts of an individual compared with society) (Table 3). Statements about individual harm (delta mean −2.30) and harm to others close to an individual (delta mean −2.18) did not significantly differ in their impact on likelihood of requesting antibiotics (p=0.11). Statements discussing antibiotic resistance (delta mean −1.91) led to a smaller reduction in likelihood to request antibiotics than statements not discussing antibiotic resistance (delta mean −2.26) (p<0.001). This difference was seen in each category of statement; that is, within the individual harm category, statements discussing antibiotic resistance were less effective than statements not discussing antibiotic resistance.

Table 3:

Mean Delta of Likelihood to Request Antibiotics Overall and by Category and Participant Characteristics

Statement Category: Individual Close
Contact
About
Society
About
Resistance
Not about
Resistance
All
Statements
Total Sample (N=250) −2.30 −2.18 −1.80 −1.91 −2.26 −2.10
Sex          
Men (N=64) −1.75 −1.49 −1.35 −1.43 −1.77 −1.62
Women (N=184) −2.81 −2.42 −2.95 −2.08 −2.43 −2.28
Education            
HS Graduate or Less (N=54) −1.90 −1.63 −1.15 −1.33 −1.72 −1.60
Any college or trade school up to bachelor's degree (N=140) −2.30 −2.33 −1.86 −1.95 −2.33 −2.16
Master's degree or higher (N=56) −2.65 −2.34 −2.25 −2.38 −2.50 −2.45
Race            
Black (N=152) −1.97 −1.94 −1.51 −1.56 −2.01 −1.81
White (N=69) −2.69 −2.41 −2.13 −2.32 −2.53 −2.44
Other (N=29) −3.09 −2.89 −2.49 −2.81 −2.88 −2.84

A mean delta“−5” meant the statement made the patient much less likely to request antibiotics, “0” meant the statement did not change their likelihood, and “5” meant the statement made them much more likely to request antibiotics. (HS stand s for High School).

Each demographic group rated individual harm statements as most effective, followed by statements about harm to others and then harm to society (Table 3). Within each category, statements had slightly different rankings, such as women rating statements involving the harm of antibiotic misuse on a pregnant woman’s child as more impactful than men did. For men, the most impactful statement was “Taking antibiotics can hurt your body’s natural defenses. This makes it easier for you to get another infection,” (delta mean −2.30) and the second most impactful was “By changing your normal gut bacteria, antibiotics can cause allergies, asthma, and stomach problems” (delta mean −2.16).

Discussion:

The results suggest that providers should focus on individual harm or harm to others close to an individual, and avoid discussing societal harm. Further, providers may wish to avoid focusing on antibiotic resistance, as discussing antibiotic resistance did not decrease participant desire for antibiotics as much as other statements. Patients likely care the most about harm that they can both understand and apply to their own life.

All statements decreased participant likelihood of requesting antibiotics, and participants were less likely to request antibiotics after completing the questionnaire. Clinicians are more likely to prescribe a non-indicated antibiotic when they perceive that patients expect one [2] [4]. Clinician communication with patients about antibiotics can increase patient awareness of antibiotic resistance and understanding of appropriate indications for an antibiotic [7]. Improving patient expectations around antibiotic use may decrease patient requests for antibiotics. Our study provides evidence that using specific statements may impact patient desire for antibiotics and provides guidance as to which of these statements are the most impactful.

Public education campaigns have frequently focused on the spread of antibiotic resistance [5] [6]. Our data suggest that this approach may not be the most effective messaging to convince an individual why they should not request non-indicated antibiotics. Antibiotic resistance is a complex topic that is poorly understood by the public [8]. For example, even though 92% of the American public agrees that inappropriate antibiotic use contributes to antibiotic resistance, only 30% believes that antibiotic resistance is a problem [3]. In administering our study, several study participants asked the study team member questions after the survey about whether antibiotic resistance was a positive or negative characteristic. Antibiotic resistance may be a complex topic to explain and to comprehend, so statements focusing on antibiotic resistance may not be as effective as statements focusing on other harms in talking to patients.

Statements focusing on harm to the individual had the greatest impact on patient likelihood to request antibiotics. It is possible that participants did not see how a global problem impacted them personally. While no research has directly measured patient consideration of individual harm from antibiotics in requesting antibiotics, recent work has shown that even when patients understand that antibiotics only treat bacteria and not viruses, they still believe that antibiotics are so low-risk for causing side effects that they may believe that the antibiotics are more likely to help than hurt symptoms of a URI [8]. In assessing evidence to this effect, recent public health campaigns have shifted towards personalizing the harm of antibiotic resistance such as by discussing possible harms such as Clostridioides difficile, allergic reactions, and antibiotic resistant infections [1]. Our study suggests that this type of information is impactful when provided in a series of short statements. Making antibiotic misuse personal may be the most effective strategy in convincing patients why they should not request non-indicated antibiotics [8].

In considering how best to dissuade a patient from non-indicated antibiotics, clinicians should keep in mind that different types of statements may have more of an impact on members of some demographic groups than others. For example, statements about the impact of pregnant women taking antibiotics on the development of babies had a greater impact on women than men. Level of educational attainment also impacted statement impact: those with a lower level of education were more likely to both initially desire antibiotics and be dissuaded by the statements than other groups. Providing education about potential harm may be most effective for those with lower levels of education.

Our quantitative examination into antibiotic resistance communication and motivations for patients to want antibiotics is novel. The relatively large study population included a high proportion of African American patients which matched the local community’s demographics and increases study applicability to similar populations. A larger multi-site study would increase generalizability of results.

The study had several limitations. Generalizability is limited as it was conducted at a single site. Additionally, as not every potential patient could be included in the study, the participants were not randomly selected, and participants may have been motivated to varying degrees by the $10 gift card provided, there was the possibility of response bias. Researchers were not allowed to approach any potential participants about the study, and had to wait for patients to approach after seeing signage. The inability to offer the survey to every patient in clinic, or to determine how many of the 1,150 patients in clinic during survey administration saw and read the advertising signage excludes the denominator necessary to calculate a response rate. The survey’s reading level was relatively high, driven by the words “antibiotic” and “resistance.” While this could have impacted participant understanding of the statements, distributing this survey without including the words “antibiotic” and “resistance” would have not been reflective of public health educational campaigns to decrease antibiotic resistance [1], [9]. This study should be validated by administration of a similar survey at multiple sites, and could be offered or administered to every patient at participating sites to improve study validity.

Conclusions:

Patient expectation of an antibiotic increases physician prescription by as much as ten times [4], and while public education campaigns have demonstrated an ability to increase patient knowledge around appropriate antibiotic usage [5] [7], little research exists addressing how best to directly dissuade a patient who is requesting non-indicated antibiotics from their request. Prior public health campaigns addressing patients have focused on antibiotic resistance and large-scale societal harm. Our research supports the approach suggested by the CDC and other stakeholder organizations to shift outpatient clinic and overall discussion towards a more individual-oriented conversation focused on harm to the individual [1]. Our research provides a list of clear statements that clinicians can use in talking with patients about antibiotics. Clinicians and public health campaigns should focus on individual side-effects or harm to others close to the patient when dissuading patients from non-indicated antibiotics, and should not emphasize societal impacts or antibiotic resistance. Whenever possible, clinicians should use statements that are simple, understandable, and directly related to the patient.

Supplementary Material

Appendix

Main point:

Prescriber statements about personal harm to patients from non-indicated antibiotic use decreased participant desire for an antibiotic prescription to treat an upper respiratory tract infection more than statements about antibiotic resistance or possible societal harm of antibiotics.

Footnotes

NOTE TO NIH: Please add that the published version of this manuscript is available for free access at: https://www.jabfm.org/content/33/6/969

Contributor Information

Benjamin J. Miller, Johns Hopkins School of Medicine, Baltimore, USA.

Kathryn A. Carson, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.

Sara Keller, Infectious Disease, Johns Hopkins Medicine, Baltimore, USA..

References:

  • [1].Center for Disease Control and Prevention. Antibiotic Resistance Threats in the United States 2019. Atlanta, Georgia: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf Accessed May 10, 2020 1–63 [Google Scholar]
  • [2].Butler C, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ 1998;317(7159):637–42 Accessed December 8, 2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Carter RR, Sun J, Jump RL. A survey and analysis of the american public's perceptions and knowledge about antibiotic resistance. Open Forum Infect Dis. 2016. May 30;3(3):ofw112. doi: 10.1093/ofid/ofw112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Sirota M, Round T. Samaranayaka, S. Kostopoulou O. Expectations for antibiotics increase their prescribing: Causal evidence about localized impact. Health Psychol. 2017. April;36(4):402–409. doi: 10.1037/hea0000456 [DOI] [PubMed] [Google Scholar]
  • [5].Hwang TJ, Gibbs KA, Podolsky SH, Linder JA. Antimicrobial stewardship and public knowledge of antibiotics. Lancet Infect Dis. 2015. September;15(9):1000–1001. doi: 10.1016/S1473-3099(15)00235-2 [DOI] [PubMed] [Google Scholar]
  • [6].O'Neill J Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. Review on antimicrobial resistance. 2014. https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf Accessed December 8, 2019 1–20 [Google Scholar]
  • [7].Trepka MJ, Belongia EA, Chyou PH, Davis JP, Schwartz B. The effect of a community intervention trial on parental knowledge and awareness of antibiotic resistance and appropriate antibiotic use in children. Pediatrics. 2001. January;107(1):E6. [DOI] [PubMed] [Google Scholar]
  • [8].Broniatowski D, Klein E, Reyna V. Germs are germs, and why not take a risk? Patients' expectations for prescribing antibiotics in an inner-city emergency department. Med Decis Making. 2015. January;35(1):60–7. doi: 10.1177/0272989X14553472 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Center for disease control and prevention. Antibiotic resistance threats in the united states. Atlanta: Report; 2013. https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf Accessed December 8, 2019 [Google Scholar]
  • [10].Russell SL, Gold MJ, Hartmann M, et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012. May 1;13(5):440–7. doi: 10.1038/embor.2012.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Kashanian M, Mohtashami SS, Bemanian MH, Moosavi SAJ, Lakeh M. Evaluation of the associations between childhood asthma and prenatal and perinatal factors. Int J Gynaecol Obstet. 2017. June;137(3):290–294. doi: 10.1002/ijgo.12141 [DOI] [PubMed] [Google Scholar]
  • [12].Lewis JD, Chen EZ, Baldassano RN, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric crohn's disease. Cell Host Microbe. 2015. October 14;18(4):489–500. doi: 10.1016/j.chom.2015.09.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Nash M, Frank D, Friedman J. Early microbes modify immune system development and metabolic homeostasis - the "restaurant" hypothesis revisited. Front Endocrinol (Lausanne). 2017. December 13;8:349. doi: 10.3389/fendo.2017.00349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Mikkelson KH, Allin KH, Knop FK. Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature. Diabetes Obes Metab. 2016. May;18(5):444–53. doi: 10.1111/dom.12637 [DOI] [PubMed] [Google Scholar]
  • [15].Cheng G, Li Z, Dai X, et al. Analysis of clostridium difficile associated diarrhea in pediatric patients with antibiotic-associated diarrhea. Zhonghua Er Ke Za Zhi. 2015. March;53(3):220–4 [PubMed] [Google Scholar]
  • [16].Jakobson HE, Jernberg C, Andersson AF, Sjolund-Karlsson M, Jansson JK, Engstrand L Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One. 2010. March 24;5(3):e9836. doi: 10.1371/journal.pone.0009836 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Khalil D, Hultin M, Rashid MU, Lund B Oral microflora and selection of resistance after a single dose of amoxicillin. Clin Microbiol Infect. 2016. November;22(11):949.e1–949.e4. doi: 10.1016/j.cmi.2016.08.008 [DOI] [PubMed] [Google Scholar]
  • [18].Filice GA, Nyman JA, Lexau C, et al. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2010. April;31(4):365–73. doi: 10.1086/651094 [DOI] [PubMed] [Google Scholar]
  • [19].Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemother. 2010. January;54(1):109–15. doi: 10.1128/AAC.01041-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Goncalves B, Ferreira C, Alves C, Henriques M, Azeredo J, Silva S Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016. November;42(6):905–27. doi: 10.3109/1040841X.2015.1091805 [DOI] [PubMed] [Google Scholar]
  • [21].O'Neill J Tackling drug-resistant infections globally: final report and recommendations. The review on antimicrobial resistance. 2016. https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf Accessed December 8, 2019 [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Appendix

RESOURCES